The symptoms precede the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute withdrawal or severe intoxication; or there is other evidence suggesting the existence of an independent non-substance/medication-induced anxiety disorder (e.g., a history of recurrent non-substance/medication-related episodes).
D. The disturbance does not occur exclusively during the course of a delirium.
E. The disturbance causes clinically significant distress or impairment in social, occupa- tional, or other important areas of functioning.
Note: This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and they are sufficiently severe to warrant clinical attention.
Coding note: The |CD-9-CM and |CD-10-CM codes for the [specific substance/medica- tion]-induced anxiety disorders are indicated in the table below. Note that the |CD-10-CM code depends on whether or not there is a comorbid substance use disorder present for the same class of substance. If a mild substance use disorder is comorbid with the sub- stance-induced anxiety disorder, the 4th position character is “1 and the clinician should record “mild [substance] use disorder" before the substance-induced anxiety disorder (e.g., “mild cocaine use disorder with cocaine-induced anxiety disorder'). It a moderate or severe substance use disorder is comorbid with the substance-induced anxiety disorder, the 4th position character is “,"2 and the clinician should record “moderate [substance] use disorder” or “severe [substance] use disorder," depending on the severity of the comorbid substance use disorder. If there is no comorbid substance use disorder (e.g., after a one- time heavy use of the substance), then the 4th position character is “9," and the clinician should record only the substance-induced anxiety disorder.
With use disorder, Without disorder, moderate use
Alcohol 291.89 F10.180 F10.280 F10.980
Caffeine 292.89 F15.180 F15.280 F15.980
Cannabis 292.89 F12.180 F12.280 F12.980
Phencyclidine 292.89 F16.180 F16.280 F16.980
Other hallucinogen 292.89 F16.180 F16.280 F16.980
Inhalant 292.89 F18.180 F18.280 F18.980
Opioid 292.89 F11.188 F11.288 F11.988
Sedative, hypnotic, or anxiolytic 292.89 F13.180 F13.280 F13.980
Amphetamine (or other 292.89 F15.180 F15.280 F15.980
Cocaine 292.89 F14.180 F14.280 F14.980
Other (or unknown) substance 292.89 F19.180 F19.280 F19.980
Specify it (see Table 1 in the chapter “Substance-Fielated and Addictive Disorders" tor di- agnoses associated with substance class):
With onset during intoxication: This specifier applies if criteria are met for intoxica- tion with the substance and the symptoms develop during intoxication.